Fertility treatment and childhood type 1 diabetes mellitus: a nationwide cohort study of 565,116 live births

Fertil Steril. 2016 Dec;106(7):1751-1756. doi: 10.1016/j.fertnstert.2016.09.009. Epub 2016 Oct 20.

Abstract

Objective: To investigate the association between specific types of fertility treatment and childhood type 1 diabetes mellitus.

Design: Nationwide birth cohort study.

Setting: Not applicable.

Patient(s): All pregnancies resulting in a live-born singleton child in Denmark from 1995 to 2003.

Intervention(s): Not applicable.

Main outcome measure(s): Childhood type 1 diabetes mellitus identified from redeemed prescriptions for insulin until 2013.

Result(s): The study included 565,116 singleton pregnancies. A total of 14,985 children were conceived by ovulation induction or intrauterine insemination, and 8,490 children were conceived by in vitro fertilization or intracytoplasmic sperm injection. During the follow-up period, 2,011 (0.4%) children developed type 1 diabetes mellitus. The primary analyses showed no association between fertility treatment and childhood type 1 diabetes mellitus. In secondary analyses, ovulation induction or intrauterine insemination with follicle-stimulating hormone was associated with an increased risk of type 1 diabetes mellitus (hazard ratio 3.22; 95% confidence interval 1.20 to 8.64). No clear associations were seen with other types of fertility treatment or with specific treatment indications.

Conclusion(s): No association between fertility treatment and childhood type 1 diabetes mellitus was found. Ovulation induction or intrauterine insemination with follicle-stimulating hormone may be associated with an increased risk of childhood type 1 diabetes mellitus. However, this finding may be due to chance or to confounding by indication and thus requires further investigation.

Keywords: Assisted reproductive technology; intracytoplasmic sperm injection; intrauterine insemination; in vitro fertilization; ovulation induction; type 1 diabetes mellitus.

MeSH terms

  • Adult
  • Age of Onset
  • Cohort Studies
  • Denmark
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / epidemiology*
  • Female
  • Fertility
  • Fertility Agents, Female / adverse effects
  • Fertilization in Vitro / adverse effects
  • Follicle Stimulating Hormone / adverse effects
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Infertility / diagnosis
  • Infertility / physiopathology
  • Infertility / therapy*
  • Insemination, Artificial / adverse effects
  • Insulin / therapeutic use
  • Live Birth
  • Male
  • Ovulation Induction / adverse effects
  • Pregnancy
  • Registries
  • Reproductive Techniques, Assisted / adverse effects*
  • Risk Assessment
  • Risk Factors
  • Sperm Injections, Intracytoplasmic / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Fertility Agents, Female
  • Hypoglycemic Agents
  • Insulin
  • Follicle Stimulating Hormone